Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples
2021 · Journal of Nanobiotechnology · 78 citations
https://doi.org/10.1186/s12951-021-01021-0
Jinan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.1K
Citations
21
h-index
29
i10-index
Wei Xiao is an academic researcher from Jinan University. The author has contributed to research in topics: Biosensors and Analytical Detection & Advanced biosensing and bioanalysis techniques & Advanced Biosensing Techniques and Applications. The author has an h-index of 21, co-authored 44 publications.
ORCID: 0000-0001-8103-6870https://doi.org/10.1186/s12951-021-01021-0
https://doi.org/10.1002/inmd.20230022
https://doi.org/10.1016/j.talanta.2024.126381
https://doi.org/10.1016/j.bios.2025.117846
Click to start Chat